Our Three-Pillar Integral Clinical Framework
Cellular Therapy Component
Umbilical cord mesenchymal stem cells form the foundation of our biological approach, delivered through precise minimally invasive intravenous and, when indicated, nebulized or regional perfusion techniques to the pulmonary circulation.
- Immunomodulatory properties
- Paracrine signaling mechanisms
- Minimally invasive systemic delivery
- Targeted lung homing
Physical Therapy Integration
Structured respiratory physiotherapy including airway clearance techniques, breathing exercises, and graded exercise training to improve lung function and functional capacity.
- Airway clearance techniques
- Inspiratory muscle training
- Graded exercise prescription
- Exacerbation prevention strategies
Nutritional Medicine Support
Targeted nutritional support designed to optimize immune function, reduce systemic inflammation, and provide essential substrates for lung tissue repair.
- Anti‑inflammatory nutritional support
- Micronutrient repletion (vitamin D, zinc)
- Antioxidant optimization
- Metabolic and weight management
Structured Clinical Approach
Comprehensive Evaluation
Detailed clinical assessment including high‑resolution CT chest, pulmonary function tests, and sputum microbiology to establish baseline status and treatment parameters.
Biological Intervention
Precise minimally invasive delivery of umbilical cord mesenchymal stem cells, followed by initial post‑procedure monitoring and care instructions.
Integrated Rehabilitation
Progressive implementation of pulmonary physiotherapy and nutritional strategies, with regular follow‑up assessments to monitor lung function and adjust protocols as needed.
Your Patient Journey Guide
Download our free comprehensive guide to the Nexus Stem Cells patient journey. Learn about logistics and travel planning, payment options, treatment timelines, post-therapy follow-up, and how our supportive rehabilitation and nutrition services integrate into your care—from your first inquiry through to discharge and recovery.
Clinical Eligibility Considerations
The following criteria generally indicate patients who are appropriate candidates for this regenerative medicine approach:
- Confirmed diagnosis of bronchiectasis via high‑resolution CT and clinical history
- Individuals experiencing recurrent exacerbations or progressive functional decline despite optimal conventional therapy
- Patients with stable disease without active malignancy or uncontrolled systemic infection
- Those with realistic expectations about treatment outcomes (slowing progression, reducing exacerbations, improving quality of life)
- Individuals committed to completing the full pulmonary rehabilitation protocol
- Adequate pulmonary reserve and overall medical stability for outpatient cellular therapy
A comprehensive medical assessment, including recent pulmonary function tests and imaging, is required to determine individual suitability for this treatment protocol.
We're Here to Support Your Journey
Contact Us to Learn More
Medical Director, Nexus Stem Cells
Our medical director oversees all clinical protocols, ensuring the highest standards of patient safety, evidence‑based practice, and regulatory compliance.
Meet Our Providers